deaths from tirzepatide In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx PDF) Tirzepatide for the Maintenance

Retatrutide is not just a GLP-1 agonist

CONSIDER THIS How Do You Choose Between Metformin and Ozempic

GLP-1RAs stand for glucagon-like peptide-1 receptor agonists

Secher, J

MeAgain's GLP-1 app addresses this by tracking doses, meals, symptoms, and weight changes in one place so users and clinicians can identify response patterns that suggest formulation differences requiring treatment adjustments

The competitive map is widening, too, as the Novo Nordisk and Eli Lilly duopoly meets oral small molecules, monthly dosing, Eli Lillys retatrutide, a triple hormone receptor agonist, has demonstrated an average weight loss of 28.3% over 80 weeks on the highest dose in Phase 3 trials